The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Rabisin



Boehringer Ingelheim Vetmedica GmbHVPA10454/074/001

Main Information

Trade NameRabisin
Active SubstancesRabies virus glycoprotein
Dosage FormSuspension for injection
Licence HolderBoehringer Ingelheim Vetmedica GmbH
Licence NumberVPA10454/074/001

Group Information

ATC CodeQI07AA02 rabies virus
Therapeutic ClassImmunological - Inactivated Vaccine
SpeciesCats
Cattle
Dogs
Horses
Other Mammals
Sheep

Status

License statusAuthorised
Licence Issued10/08/2004
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product Characteristics *PDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
VariationsNo document available

* The PDF document, together with the national-specific product information on this page, constitute the authorised SPC
« Back